Terms: = Kidney tumors AND ELN, ENSG00000049540, 2006, WS, WBS, SVAS, FLJ43523, FLJ38671 AND Prognosis
144 results:
1. Natural history of bone-only metastasis in renal cell carcinoma.
Tang B; Duan R; Fan Z; Yan X; Li S; Zhou L; Li J; Xu H; Mao L; Lian B; Wang X; Bai X; Wei X; Li C; Cui C; Si L; Chi Z; Guo J; Sheng X
Urol Oncol; 2024 Apr; 42(4):119.e17-119.e22. PubMed ID: 38383241
[TBL] [Abstract] [Full Text] [Related]
2. Proteinuria frequency and subsequent renal dysfunction in bevacizumab-treated patients: a single center, retrospective, observational study.
Kataoka S; Nishikawa Y; Funakoshi T; Horimatsu T; Sakuragi M; Uchino E; Hiragi S; Yamamoto S; Sakai K; Matsubara T; Yanagita M; Muto M
Int J Clin Oncol; 2024 Apr; 29(4):398-406. PubMed ID: 38351273
[TBL] [Abstract] [Full Text] [Related]
3. Assessment of Ki-67 proliferation index in prognosis prediction in patients with nonmetastatic clear cell renal cell carcinoma and tumor thrombus.
Zhao J; Ding X; Peng C; Tian X; Wang M; Fu Y; Guo H; Bai X; Zhai X; Huang Q; Liu K; Li L; Ye H; Zhang X; Ma X; Wang H
Urol Oncol; 2024 Jan; 42(1):23.e5-23.e13. PubMed ID: 38030468
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic value and model construction of preoperative inflammatory markers in patients with metastatic renal cell carcinoma.
Wang J; Ye J; Zhao X; Li X; Ma X
World J Surg Oncol; 2023 Jul; 21(1):211. PubMed ID: 37480143
[TBL] [Abstract] [Full Text] [Related]
5. A multi-institutional retrospective study of 340 cases of sinonasal malignant tumor.
Tsuji T; Asato R; Kada S; Kitamura M; Tamaki H; Mizuta M; Tanaka S; Watanabe Y; Hori R; Kojima T; Shinohara S; Takebayashi S; Maetani T; Harada H; Kitani Y; Kumabe Y; Tsujimura T; Honda K; Ichimaru K; Ushiro K; Omori K
Auris Nasus Larynx; 2024 Feb; 51(1):86-98. PubMed ID: 37248104
[TBL] [Abstract] [Full Text] [Related]
6. Real World Data of Diagnosis, Survival, and Treatment Outcomes in Patients With Metastatic Non Clear Cell Renal Cell Carcinoma.
Izarn F; Allignet B; Gille R; Boyle H; Neidhardt EM; Négrier S; Fléchon A
Clin Genitourin Cancer; 2023 Apr; 21(2):e35-e43. PubMed ID: 36272959
[TBL] [Abstract] [Full Text] [Related]
7. Analysis and Prediction of the Survival Trends of Patients with Clear-Cell Renal Cell Carcinoma: A Model-Based Period Analysis, 2001-2015.
Du S; Zhong Y; Zheng S; Lyu J
Cancer Control; 2022; 29():10732748221121226. PubMed ID: 35981235
[TBL] [Abstract] [Full Text] [Related]
8. Conditional Survival of Patients With Extracranial Oligometastatic Treated With Stereotactic Body Radiation Therapy: An International Consortium Study.
Chen H; Badellino S; Biswas T; Dagan R; Erler D; Foote M; Poon I; Redmond KJ; Ricardi U; Sahgal A; Louie AV
Int J Radiat Oncol Biol Phys; 2022 Dec; 114(5):902-909. PubMed ID: 35753554
[TBL] [Abstract] [Full Text] [Related]
9. Renal Cell Carcinoma Metastasis to the Left Atrium.
Ali A; Shah S; Furrukh M
Tex Heart Inst J; 2022 May; 49(3):. PubMed ID: 35675083
[TBL] [Abstract] [Full Text] [Related]
10. Systemic Therapy in Patients With Metastatic Xp11.2 Translocation Renal Cell Carcinoma.
Yan X; Zhou L; Li S; Wu X; Cui C; Chi Z; Si L; Kong Y; Tang B; Li C; Mao L; Wang X; Lian B; Bai X; Dai J; Guo J; Sheng X
Clin Genitourin Cancer; 2022 Aug; 20(4):354-362. PubMed ID: 35387755
[TBL] [Abstract] [Full Text] [Related]
11. MMP-9 secreted by M2-type macrophages promotes Wilms' tumour metastasis through the PI3K/AKT pathway.
Tian K; Du G; Wang X; Wu X; Li L; Liu W; Wu R
Mol Biol Rep; 2022 May; 49(5):3469-3480. PubMed ID: 35107742
[TBL] [Abstract] [Full Text] [Related]
12. Impact of comorbidity on renal cell carcinoma prognosis: a nationwide cohort study.
Horsbøl TA; Dalton SO; Christensen J; Petersen AC; Azawi N; Donskov F; Holm ML; Nørgaard M; Lund L
Acta Oncol; 2022 Jan; 61(1):58-63. PubMed ID: 34807805
[TBL] [Abstract] [Full Text] [Related]
13. Long-term outcome in patients with takotsubo syndrome : A single center study from Vienna.
Pogran E; Abd El-Razek A; Gargiulo L; Weihs V; Kaufmann C; Horváth S; Geppert A; Nürnberg M; Wessely E; Smetana P; Huber K
Wien Klin Wochenschr; 2022 Apr; 134(7-8):261-268. PubMed ID: 34415428
[TBL] [Abstract] [Full Text] [Related]
14. Predictors of postoperative recurrence in patients with non-metastatic pT3a renal cell carcinoma.
Ohsugi H; Ohe C; Yoshida T; Ikeda J; Sugi M; Kinoshita H; Matsuda T
Int J Urol; 2021 Oct; 28(10):1060-1066. PubMed ID: 34346110
[TBL] [Abstract] [Full Text] [Related]
15. Impact of Primary Tumor Size on prognosis in Patients With Metastatic Renal Cell Carcinoma Receiving Cytoreductive Nephrectomy: A Population Study of a Chinese Center and the US SEER Database.
Jiang W; Shou J; Shi H; Wen L; Zhang H; Zheng S; Li C; Ma J
Technol Cancer Res Treat; 2021; 20():15330338211019507. PubMed ID: 34032149
[TBL] [Abstract] [Full Text] [Related]
16. Pattern, timing and predictors of recurrence after surgical resection of chromophobe renal cell carcinoma.
Neves JB; Vanaclocha Saiz L; Abu-Ghanem Y; Marchetti M; Tran-Dang MA; El-Sheikh S; Barod R; Beisland C; Capitanio U; Cullen D; Klatte T; Ljungberg B; Mumtaz F; Patki P; Stewart GD; Dabestani S; Tran MGB; Bex A;
World J Urol; 2021 Oct; 39(10):3823-3831. PubMed ID: 33851271
[TBL] [Abstract] [Full Text] [Related]
17. Should patients with low-risk renal cell carcinoma be followed differently after nephron-sparing surgery vs radical nephrectomy?
Abu-Ghanem Y; Powles T; Capitanio U; Beisland C; Järvinen P; Stewart GD; Gudmundsson E; Lam TBL; Marconi L; Fernandéz-Pello S; Nisen H; Meijer RP; Volpe A; Ljungberg B; Klatte T; Bensalah K; Dabestani S; Bex A
BJU Int; 2021 Sep; 128(3):386-394. PubMed ID: 33794055
[TBL] [Abstract] [Full Text] [Related]
18. Significance of preoperative hematologic scoring in predicting death among patients with non-metastatic renal cell carcinoma undergoing nephrectomy.
Attawettayanon W; Choorit T; Chalieopanyarwong V; Pripatnanont C
Asian J Surg; 2021 Jul; 44(7):952-956. PubMed ID: 33622600
[TBL] [Abstract] [Full Text] [Related]
19. [Clinicopathological features and differential diagnosis of eosionphilic chromophobe renal cell carcinoma].
Zhang W; Song TT; He B; Wang H; Kang EH; Yu WJ; Zhong DC; Jiang YX; Li YJ
Zhonghua Bing Li Xue Za Zhi; 2020 Dec; 49(12):1242-1248. PubMed ID: 33287507
[No Abstract] [Full Text] [Related]
20. PD-L1 and VEGFR-2 expression in synchronous metastatic renal cell carcinoma treated with targeted therapy following cytoreductive nephrectomy.
Jiang W; Wang D; Liu X; Zheng W; Wen L; Shi H; Zhang H; Zhou A; Li C; Ma J; Zheng S; Shou J
Urol Oncol; 2021 Jan; 39(1):78.e9-78.e16. PubMed ID: 32988712
[TBL] [Abstract] [Full Text] [Related]
[Next]
